RARE-X and the Broad Institute of MIT and Harvard Partner to Advance Efforts in Patient-Powered Data Collection and Sharing
Share Article
Both organizations have aligned around mission and purpose to deliver transformative technology improving human health globally by delivering value for patients and supporting future rare disease research. By bringing Broad s expertise in data generation and data analysis together with RARE-X s capabilities in patient engagement and patient advocacy, we can work to accelerate progress in science and medicine, said Anthony Philippakis, chief data officer for the Broad Institute of Harvard and MIT. ALISO VIEJO, Calif. (PRWEB) May 11, 2021
RARE-X has announced a collaboration with the Broad Institute of MIT and Harvard, leveraging innovative technology to support new data-collection approaches, data governance, and data sharing. Through their partnership, these non-profit organi
Date Time
New commissioners appointed to Commission on Human Medicines
Professor Amanda Adler, Professor Sandosh Padmanabhan, Professor Steve Cunningham and Professor Yvonne Perrie have been appointed as Commissioners of the CHM for four years, in accordance with the Cabinet Office Code of Governance for Public Appointments.
The CHM provides independent expert advice to ministers on the safety, quality and efficacy of medicines, and on adverse reactions including those reported under the Yellow Card Scheme. It is an advisory non-departmental public body, sponsored by the Department of Health and Social Care.
Sandosh Padmanabhan, Professor of Cardiovascular Genomics and Therapeutics at the University of Glasgow and the University of Toledo, said:
New commissioners appointed to the Commission on Human Medicines
Four new Commissioners will join the Commission on Human Medicines (CHM) on 1 May 2021.
From:
30 April 2021
Professor Amanda Adler, Professor Sandosh Padmanabhan, Professor Steve Cunningham and Professor Yvonne Perrie have been appointed as Commissioners of the CHM for four years, in accordance with the Cabinet Office Code of Governance for Public Appointments.
The CHM provides independent expert advice to ministers on the safety, quality and efficacy of medicines, and on adverse reactions including those reported under the Yellow Card Scheme. It is an advisory non-departmental public body, sponsored by the Department of Health and Social Care.
WHO’s COVID-19 Origins Team Member Says ‘Demonstrably False’ Attacks on Report ‘Undermine Science’
Subscribe
Sputnik International
https://sputniknews.com/science/202104011082514269-whos-covid-19-origins-team-member-says-demonstrably-false-attacks-on-report-undermine-science/
Since before the the 12-nation team of scientists visited Wuhan, China, earlier this year in an attempt to discover the origins of the virus responsible for the COVID-19 pandemic, Western nations and corporate media outlets were claiming China would block their efforts, reviving politically useful but scientifically discredited conspiracy theories.
In the wake of the World Health Organization (WHO) team’s report from Wuhan on the origins of SARS-CoV-2, the virus that causes COVID-19, the US and its allies have cried foul, claiming the Chinese government fouled their investigation after it failed to point the finger at Beijing. However, the scientists who led the probe are now pushing back, sayin
Pius Utomi Ekpei / AFP via Getty Images
In late December, 2013, a 18-month-old boy in a small village in southern Guinea died two days after contracting a mysterious disease. By the middle of January, 2014, several members of his family fell ill with the same symptoms: fever, vomiting and black stools. Two months later the cause of the outbreak was identified: Ebola virus. The subsequent epidemic hit West Africa hard, infecting more than 28,000 people and killing 11,325. Cases were also reported in Italy, Spain, the UK and the US.
Christian Happi was the first person to diagnose a case of Ebola in Nigeria, and helped to sequence the virus. But Happi, a professor of molecular biology and genomics at the Redeemer’s University in Nigeria, was frustrated by how inadequate the response was. Hospitals were sharing information through paper, or Excel, if they even had electricity. “There was no coordination,” he says. “It was a big mess.”